| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | May 15, 2025 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -4,000 | -3.59% | ✗ | $241.8K |
| Mar 7, 2025 | Mar 14, 2025 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -2,874 | -2.52% | ✗ | $174.2K |
| Feb 28, 2025 | Mar 4, 2025 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -1,275 | -1.10% | ✗ | $78.9K |
| Feb 12, 2025 | Feb 18, 2025 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 95.0 | +38,689 | 50.39% | ✗ | $156.6K |
| Nov 15, 2024 | Nov 18, 2024 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 20.0 | -6,500 | -7.81% | ✗ | $375.1K |
| May 21, 2024 | May 22, 2024 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -2,000 | -2.35% | ✗ | $123.2K |
| Mar 7, 2024 | Mar 7, 2024 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -2,110 | -2.41% | ✗ | $140.8K |
| Mar 5, 2024 | Mar 6, 2024 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 20.0 | -5,000 | -5.41% | ✗ | $330K |
| Feb 29, 2024 | Mar 1, 2024 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -1,275 | -1.36% | ✗ | $86.3K |
| Feb 15, 2024 | Feb 20, 2024 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -1,261 | -1.33% | ✗ | $72.6K |
| Nov 10, 2023 | Nov 13, 2023 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -3,000 | -4.50% | ✗ | $157.4K |
| Mar 7, 2023 | Mar 9, 2023 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -1,902 | -4.81% | ✗ | $84.1K |
| Feb 15, 2023 | Feb 17, 2023 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 22.5 | -1,292 | -3.16% | ✗ | $58.2K |
| Feb 15, 2022 | Feb 17, 2022 | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | Sell | 26.3 | -1,184 | -7.34% | ✗ | $47.7K |